averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
OVOL1
|
ENSG00000172818.5 | ovo like transcriptional repressor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
OVOL1 | hg19_v2_chr11_+_65554493_65554546 | 0.20 | 3.0e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_84419101 | 5.34 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr10_-_73848086 | 3.44 |
ENST00000536168.1
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr10_-_21786179 | 3.39 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr10_-_73848764 | 3.24 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr5_+_140739537 | 3.16 |
ENST00000522605.1
|
PCDHGB2
|
protocadherin gamma subfamily B, 2 |
chr10_-_73848531 | 2.86 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr5_-_16509101 | 2.46 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
chr5_+_140261703 | 1.88 |
ENST00000409494.1
ENST00000289272.2 |
PCDHA13
|
protocadherin alpha 13 |
chr1_+_174846570 | 1.45 |
ENST00000392064.2
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr3_-_165555200 | 1.18 |
ENST00000479451.1
ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE
|
butyrylcholinesterase |
chr2_-_183387064 | 0.98 |
ENST00000536095.1
ENST00000331935.6 ENST00000358139.2 ENST00000456212.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr2_-_183387283 | 0.88 |
ENST00000435564.1
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr14_+_29241910 | 0.85 |
ENST00000399387.4
ENST00000552957.1 ENST00000548213.1 |
C14orf23
|
chromosome 14 open reading frame 23 |
chr4_+_39408470 | 0.84 |
ENST00000257408.4
|
KLB
|
klotho beta |
chr17_-_7145475 | 0.80 |
ENST00000571129.1
ENST00000571253.1 ENST00000573928.1 |
GABARAP
|
GABA(A) receptor-associated protein |
chr7_-_38389573 | 0.57 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
chr7_+_119913688 | 0.56 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
chr2_-_183387430 | 0.51 |
ENST00000410103.1
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr19_-_46296011 | 0.46 |
ENST00000377735.3
ENST00000270223.6 |
DMWD
|
dystrophia myotonica, WD repeat containing |
chr11_-_75017734 | 0.18 |
ENST00000532525.1
|
ARRB1
|
arrestin, beta 1 |
chr15_+_75335604 | 0.06 |
ENST00000563393.1
|
PPCDC
|
phosphopantothenoylcysteine decarboxylase |
chr20_+_54823788 | 0.03 |
ENST00000243911.2
|
MC3R
|
melanocortin 3 receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 5.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 2.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 5.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0090240 | follicle-stimulating hormone signaling pathway(GO:0042699) positive regulation of histone H4 acetylation(GO:0090240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 5.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 9.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 9.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 1.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.2 | 5.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.0 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 9.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |